Turn Therapeutics Inc.

NASDAQ:TTRX

Biotechnology

Healthcare
$8.64 -2.79%

-$0.17 today

Market cap
$264.15M
Beta
2.77
P/E (TTM)
-45.0
EPS (TTM)
-$0.13
52W Low $2.57High $26.50

Volume 0.13M

Average 0.04M

Balance Sheet

Inspect the capital base behind the business.

Assets

$12.16M

FY 2025 · Annual

+493.6% YoY

Liabilities

$7.48M

FY 2025 · Annual

+235.8% YoY

Equity

$4.69M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.18M872.6K5.08M
Short-term Investments000
Net Receivables000
Inventory000
Other Current Assets20.82K225.33K0
Total Current Assets1.2M1.1M5.2M
Property, Plant & Equipment (Net)33.22K120.45K0
Goodwill000
Intangible Assets769.94K821.93K922.17K
Long-term Investments000
Tax Assets000
Other Non-current Assets8.58K8.58K6.04M
Total Non-current Assets811.74K950.97K6.97M
Total Assets2.01M2.05M12.16M
Account Payables002.93M
Short-term Debt000
Tax Payables000
Deferred Revenue000
Other Current Liabilities464.62K667.27K3.03M
Total Current Liabilities489.78K707.93K6M
Long-term Debt000
Deferred Tax Liabilities000
Deferred Revenue (Non-current)1.44M1.44M1.44M
Other Non-current Liabilities000
Total Non-current Liabilities1.44M1.52M1.47M
Total Liabilities1.93M2.23M7.48M
Common Stock1.32K1.34K2.94K
Retained Earnings(17.43M)(19.2M)(22.39M)
Accumulated OCI000
Other Stockholders Equity00(1.07M)
Minority Interest000
Total Equity85.77K(177.43K)4.69M
Total Debt25.16K121.04K80.38K
Net Debt(1.16M)(751.56K)(5M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$11.2M
Other Current$235.2K
Total Current Assets$11.5M
PP&E (Net)$67.6K
Intangible Assets$919.9K
Other Non-current$6.2M
Total Non-current Assets$7.2M
Total Assets$18.6M

Analysis

Selected assets total $18.6M for Latest. The largest visible component is Cash & Equivalents at $11.2M, about 60.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
S-3S-3 filingNov 9, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
S-3S-3 filingNov 9, 2026

How much cash does TTRX have?

Turn Therapeutics Inc. (TTRX) reported $5.08M in cash and equivalents in fiscal 2025.

How much debt does TTRX carry?

Turn Therapeutics Inc. (TTRX) reported $80,376.00 of total debt, with net debt of -$5.00M.